The real 10-year rate recently went negative again. So why aren't we feverishly rebuilding our infrastructure, when borrowing is practically free?!
CNBC's Steve Liesman reports the latest on Chicago Fed President Charlie Evans' comments on a rate hike and inflation.
Betting on quality growth with Cognizant Technology Solutions.
All the high-ranking GOPers defecting from the Trump camp need to get over themselves and realize what's going on in the party, says Jake Novak.
A daily morning look at the financial stories you need to know to start the day.
Shares of Royal Caribbean sank after the cruise line's second-quarter earnings release.
CNBC's Meg Tirrell discusses Biogen drawing interest from Merck and Allergan, as possible acquisition, according to Dow Jones.
Biogen gets interest from Merck and Allergan, according to Dow Jones.
Andy Hargreaves, Pacific Crest Securities, looks at Disney's warning on ESPN subscribers, a year after the fact.
CNBC's Kelly Evans talks to the CEO of Southern Company about his company's business and the future of energy.
Karl Brauer, Kelley Blue Book, discusses slowing auto sales in the month of July.
CNBC's Julia Boorstin reports on where the "skinny bundle" stands today.
Which billionaire endorsements carry the most weight, with CNBC Contributor Larry Kudlow and consultant Eric Dezenhall.
Warren Buffett goes after Donald Trump on taxes and business acumen. He joins Mark Cuban, Michael Bloomberg and Oprah Winfrey as billionaires who've taken on Trump. CNBC's John Harwood reports.
A deeper dive into this week's economic data, with CNBC's Steve Liesman; Michelle Meyer, Bank of America Merrill Lynch; and Danielle Booth, Money Strong.
Parents of "Star Trek" actor Anton Yelchin file a wrongful death lawsuit against Fiat Chrysler over a rollaway accident. CNBC's Phil LeBeau reports.
CNBC's Meg Tirrell reports on Theranos founder Elizabeth Holmes's efforts to make the case for her company's blood-testing device.
Liuba Belkin, Lehigh University, discusses the problem of email overload during the workweek.
CNBC's Melissa Lee looks at good, bad and ugly stocks, including CVS and Generac.